Core needle biopsy (CNB), as an initial procedure in breast cancer (BC) diagnosis, is widely used and recommended to test tumor biomarkers, such as hormonal receptor (HR), human epidermal growth factor receptor 2 (HER2), and Ki67 status. Here, ERBB2 is linked to neoplasm.